Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
Iben Lyskjær, Christopher Davies, Anna-Christina Strobl, et al.
A list of publications arising from our work is shown below. If you know of a relevant publication not listed here, please let us know via email.
6 publications
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
Iben Lyskjær, Christopher Davies, Anna-Christina Strobl, et al.
Validation of clinical-grade whole genome sequencing reproduces cytogenetic analysis and identifies mutational landscape in newly-diagnosed multiple myeloma patients: A pilot study from the 100,000 Genomes Project
Oliver C. Lomas, Sarah Gooding, Maite Cabes, et al.
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples
Louise de Schaetzen van Brienen, Maarten Larmuseau, Kim Van der Eecken, et al.
Clinical-Grade Whole Genome Sequencing Reproduces FISH Cytogenetics and Provides Actionable Data in Newly Diagnosed Myeloma – a Pilot Study from the UK 100,000 Genomes Project
Oliver Lomas, Sarah Gooding, Karthik Ramasamy, et al.
Validating Whole Genome Sequencing (WGS) for clinical use in AML & ALL
S. Henderson, A. Sosinsky, A. Hamblin, et al.